News from us and our partners

Tags

Topics

0 results

News
13 November, 2017
ProQR Doses First LCA 10 Patient in Clinical Trial of QR-110, ProQR’s Lead Program for Genetic Blindness
News
10 November, 2017
Inotrem et Roche Diagnostics signent un accord de collaboration R&D pour développer un test diagnostic dans le domaine du choc septique.
News
10 November, 2017
Inotrem and Roche Diagnostics sign a R&D collaboration agreement in the field of septic shock to develop a companion diagnostic test
News
31 October, 2017
Highlife lève 12.3M€ lors d'un tour de financement mené par Sofinnova Partners
News
31 October, 2017
Highlife closes €12.3 million financing round led by Sofinnova Partners
News
20 October, 2017
Avantium nominates Kees Verhaar as supervisory board chair
News
19 October, 2017
Pixium Vision receives approval for First-in-Human Clinical Trial of PRIMA, its miniaturized sub-retinal implant
News
18 October, 2017
Dr. Jan van de Winkel Joins Hookipa as Chairman of its Board of Directors
News
11 October, 2017
Shockwave Medical Announces $35 Million in New Financing
News
9 October, 2017
la Relève" Les Echos
News
3 October, 2017
Noxxon publie des données précliniques de preuve de concept relatives à l'association du composé phare NOX-A12 à des inhibiteurs de point de contrôle
News
30 September, 2017
Nucana plc announces pricing of initial public offering
News
29 September, 2017
Noxxon provides update ongoing phase 1/2 clinical trial with lead program NOX-A12
News
27 September, 2017
Henrijette Richter appointed Managing Partner of Sofinnova Partners
News
27 September, 2017
Henrijette Richter est promue Managing Partner de Sofinnova Partners
News
19 September, 2017
Synthace raises £7.3m to accelerate biotechnology to enable faster breakthroughs

ProQR Doses First LCA 10 Patient in Clinical Trial of QR-110, ProQR’s Lead Program for Genetic Blindness

Inotrem et Roche Diagnostics signent un accord de collaboration R&D pour développer un test diagnostic dans le domaine du choc septique.

Inotrem and Roche Diagnostics sign a R&D collaboration agreement in the field of septic shock to develop a companion diagnostic test

Highlife lève 12.3M€ lors d'un tour de financement mené par Sofinnova Partners

Highlife closes €12.3 million financing round led by Sofinnova Partners

Avantium nominates Kees Verhaar as supervisory board chair

Pixium Vision receives approval for First-in-Human Clinical Trial of PRIMA, its miniaturized sub-retinal implant

Dr. Jan van de Winkel Joins Hookipa as Chairman of its Board of Directors

Shockwave Medical Announces $35 Million in New Financing

la Relève" Les Echos

Noxxon publie des données précliniques de preuve de concept relatives à l'association du composé phare NOX-A12 à des inhibiteurs de point de contrôle

Nucana plc announces pricing of initial public offering

Noxxon provides update ongoing phase 1/2 clinical trial with lead program NOX-A12

Henrijette Richter appointed Managing Partner of Sofinnova Partners

Henrijette Richter est promue Managing Partner de Sofinnova Partners

Synthace raises £7.3m to accelerate biotechnology to enable faster breakthroughs